Guidelines for the diagnosis and treatment of Chronic Heart Failure: full text (update 2005) The Task Force for the diagnosis and treatment of CHF of the European Society of Cardiology

[1]  Cynthia D. Mulrow,et al.  How well can the chest radiograph diagnose left ventricular dysfunction? , 1996, Journal of General Internal Medicine.

[2]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[3]  A. Cohen-Solal,et al.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). , 2005, European heart journal.

[4]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[5]  K. Swedberg,et al.  [Expert Consensus document on beta-adrenergic receptor blockers]. , 2004, Revista espanola de cardiologia.

[6]  Akshay S. Desai,et al.  Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. , 2005, JAMA.

[7]  S. Jauhar,et al.  The Economics of ICDs. , 2004, The New England journal of medicine.

[8]  Ralph D'Agostino,et al.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. , 2004, The New England journal of medicine.

[9]  S. Solomon,et al.  Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction: Results of the CHARM Low–Left Ventricular Ejection Fraction Trials , 2004, Circulation.

[10]  D. Burkhoff,et al.  Diastolic dysfunction: can it be diagnosed by Doppler echocardiography? , 2004, Journal of the American College of Cardiology.

[11]  F. Rodríguez‐Artalejo,et al.  The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. , 2004, European heart journal.

[12]  J. McMurray,et al.  Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. , 2004, Journal of the American College of Cardiology.

[13]  A. Laupacis,et al.  Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study , 2004 .

[14]  P A Poole-Wilson,et al.  The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. , 2004, American heart journal.

[15]  N. Freemantle,et al.  Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure , 2004, European journal of heart failure.

[16]  Hugh Calkins,et al.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.

[17]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[18]  A. Coats,et al.  Life-Years Gained From Defibrillator Implantation: Markedly Nonlinear Increase During 3 Years of Follow-Up and Its Implications , 2004, Circulation.

[19]  Brian Olshansky,et al.  The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. , 2004, Journal of the American College of Cardiology.

[20]  Robert Fair,et al.  Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. , 2004, Journal of the American College of Cardiology.

[21]  G. Guyatt,et al.  Digitalis for treatment of congestive heart failure in patients in sinus rhythm: a systematic review and meta-analysis. , 2004, Journal of cardiac failure.

[22]  K. Swedberg,et al.  Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. , 2004, Journal of the American College of Cardiology.

[23]  M. Pfeffer,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both , 2004 .

[24]  U. Khot,et al.  Prognostic importance of physical examination for heart failure in non-St-elevation acute coronary syndromes the enduring value of Killip classification , 2004 .

[25]  James C Moon,et al.  Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. , 2004, American heart journal.

[26]  M. Simon,et al.  Peak oxygen consumption and outcome in heart failure patients chronically treated with beta-blockers. , 2004, Journal of cardiac failure.

[27]  M. Piepoli,et al.  Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) , 2004, BMJ : British Medical Journal.

[28]  C. O'connor,et al.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. , 2004, Journal of the American College of Cardiology.

[29]  K. Swedberg,et al.  Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. , 2003, European heart journal.

[30]  U. Janssens,et al.  Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. , 2004, American heart journal.

[31]  J. Cleland,et al.  Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? , 2003, Journal of the American College of Cardiology.

[32]  D. Atar,et al.  Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study , 2003, BMJ : British Medical Journal.

[33]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[34]  F. Turnbull.  Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.

[35]  E. Topol,et al.  Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. , 2003, JAMA.

[36]  M. Pfeffer,et al.  Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. , 2003, Journal of the American College of Cardiology.

[37]  M. Böhm,et al.  Increased exercise ejection fraction and reversed remodeling after long‐term treatment with metoprolol in congestive heart failure: a randomized, stratified, double‐blind, placebo‐controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy , 2003, European journal of heart failure.

[38]  Arthur W Wallace,et al.  Myosplint decreases wall stress without depressing function in the failing heart: a finite element model study. , 2003, The Annals of thoracic surgery.

[39]  N. Smedira,et al.  Global surgical experience with the Acorn cardiac support device. , 2003, The Journal of thoracic and cardiovascular surgery.

[40]  T. Gerber,et al.  Clinical safety of magnetic resonance imaging early after coronary artery stent placement. , 2003, Journal of the American College of Cardiology.

[41]  N. Freemantle,et al.  Clinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEM , 2003, European journal of heart failure.

[42]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[43]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial , 2003, The Lancet.

[44]  M. Pfeffer,et al.  Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme , 2003, The Lancet.

[45]  D. Levy,et al.  Natural History of Asymptomatic Left Ventricular Systolic Dysfunction in the Community , 2003, Circulation.

[46]  C. Yancy.  Does race matter in heart failure? , 2003, American heart journal.

[47]  M. Drazner,et al.  B-type natriuretic peptide in cardiovascular disease , 2003, The Lancet.

[48]  Heikki V Huikuri,et al.  Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. , 2003, Circulation.

[49]  P. Macfarlane,et al.  Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial , 2003, The Lancet.

[50]  P. Poole‐Wilson,et al.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.

[51]  P. McCarthy,et al.  Device‐Based Left Ventricular Geometry Change for Heart Failure Treatment: , 2003, Journal of cardiac surgery.

[52]  A. Mansur,et al.  Periodic breathing during incremental exercise predicts mortality in patients with chronic heart failure evaluated for cardiac transplantation. , 2003, Journal of the American College of Cardiology.

[53]  S. Hohnloser,et al.  Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. , 2003, Journal of the American College of Cardiology.

[54]  H. Joller-jemelka,et al.  Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. , 2003, Journal of the American College of Cardiology.

[55]  M. Pfeffer,et al.  Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure—Assessment of Reduction in Mortality and morbidity (CHARM) programme , 2003, European journal of heart failure.

[56]  A. Hoes,et al.  Predicting mortality in patients with heart failure: a pragmatic approach , 2003, Heart.

[57]  N. Freemantle,et al.  The heart failure revascularisation trial (HEART): rationale, design and methodology , 2003, European journal of heart failure.

[58]  L. Levin,et al.  Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure: results from a prospective, randomised trial. , 2003, European heart journal.

[59]  I. Squire,et al.  Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993–2001 , 2003, Heart.

[60]  S. Yusuf,et al.  Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study , 2003, The Lancet.

[61]  M. Pfeffer,et al.  Left Ventricular Remodeling and Ventricular Arrhythmias After Myocardial Infarction , 2003, Circulation.

[62]  L. Stevenson,et al.  Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. , 2003, Journal of the American College of Cardiology.

[63]  M. Zile.  Heart failure with preserved ejection fraction: is this diastolic heart failure? , 2003, Journal of the American College of Cardiology.

[64]  B. Brendorp,et al.  Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. , 2003, European heart journal.

[65]  B. Radovancević,et al.  Prolonged QTc Interval and High B-Type Natriuretic Peptide Levels Together Predict Mortality in Patients With Advanced Heart Failure , 2003, Circulation.

[66]  B. Pitt,et al.  Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[67]  Abdissa Negassa,et al.  Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study , 2003, The Lancet.

[68]  N Freemantle,et al.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.

[69]  J. McMurray,et al.  It cannot be cardiac failure because the heart is not enlarged on the chest X‐ray , 2003, European journal of heart failure.

[70]  T. Simon,et al.  Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II). , 2003, European heart journal.

[71]  Harlan M Krumholz,et al.  Association of serum digoxin concentration and outcomes in patients with heart failure. , 2003, JAMA.

[72]  S. Goodman,et al.  Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. , 2003, JAMA.

[73]  D. Kass,et al.  Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations , 2003, Circulation.

[74]  R. Maestri,et al.  Short-Term Heart Rate Variability Strongly Predicts Sudden Cardiac Death in Chronic Heart Failure Patients , 2003, Circulation.

[75]  Paul W Armstrong,et al.  Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.

[76]  G. Naccarelli,et al.  Atrial fibrillation in patients with heart failure , 2003, Current opinion in cardiology.

[77]  G. Ewald,et al.  The effect of β-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure , 2003 .

[78]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[79]  N. Freemantle,et al.  Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey , 2002, The Lancet.

[80]  R. Prescott,et al.  Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. , 2002, Journal of the American College of Cardiology.

[81]  Harlan M Krumholz,et al.  Sex-based differences in the effect of digoxin for the treatment of heart failure. , 2002, The New England journal of medicine.

[82]  R. Kim,et al.  Reproducibility of Chronic Infarct Size Measurement by Contrast-Enhanced Magnetic Resonance Imaging , 2002, Circulation.

[83]  J. Cohn,et al.  Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. , 2002, Journal of the American College of Cardiology.

[84]  R. Collins,et al.  Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review , 2002, The Lancet.

[85]  M. Metra,et al.  Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. , 2002, Journal of the American College of Cardiology.

[86]  K. Dickstein,et al.  Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial , 2002, The Lancet.

[87]  Douglas W Mahoney,et al.  Plasma brain natriuretic peptide concentration: impact of age and gender. , 2002, Journal of the American College of Cardiology.

[88]  Robert J Cody,et al.  Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. , 2002, American heart journal.

[89]  B. Fagerberg,et al.  Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF). , 2002, Journal of the American College of Cardiology.

[90]  J. Cleland,et al.  Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial , 2002, The Lancet.

[91]  Alan S Maisel,et al.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.

[92]  Thomas Lavergne,et al.  Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. , 2002, Journal of the American College of Cardiology.

[93]  M. Davies,et al.  Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations , 2002, BMJ : British Medical Journal.

[94]  L. Goldman,et al.  Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.

[95]  G. Fonarow,et al.  Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. , 2002, Journal of the American College of Cardiology.

[96]  Lemuel A Moyé,et al.  Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction. , 2002, Journal of the American College of Cardiology.

[97]  M. Emdin,et al.  The Circulating Levels of Cardiac Natriuretic Hormones in Healthy Adults: Effects of Age and Sex , 2002, Clinical chemistry and laboratory medicine.

[98]  R. Califf,et al.  Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. , 2002, JAMA.

[99]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[100]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[101]  P. Giannuzzi,et al.  Ventilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity. , 2002, American heart journal.

[102]  Luigi Tavazzi,et al.  Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. , 2002, American heart journal.

[103]  R. McKelvie,et al.  Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials. , 2002, Journal of the American College of Cardiology.

[104]  P. Poole‐Wilson,et al.  Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. , 2002, International journal of cardiology.

[105]  C. O'connor,et al.  A standardized definition of ischemic cardiomyopathy for use in clinical research. , 2002, Journal of the American College of Cardiology.

[106]  E. Lewis,et al.  Renoprotective effects of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes , 2002 .

[107]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy , 2002 .

[108]  L. Tavazzi,et al.  Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). , 2002, American heart journal.

[109]  G. Breithardt,et al.  [Task Force on Sudden Cardiac Death, European Society of Cardiology. Summary of recommendations]. , 2002, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[110]  J. Cohn,et al.  A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. , 2001, The New England journal of medicine.

[111]  P. Hildebrandt,et al.  Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations , 2001, European journal of heart failure.

[112]  A. Levey,et al.  Prediction equations to estimate glomerular filtration rate: an update , 2001, Current opinion in nephrology and hypertension.

[113]  Melissa M Deer,et al.  Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. , 2001, The American journal of medicine.

[114]  A. Gavazzi,et al.  [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[115]  V. Fuster,et al.  ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference , 2001, Circulation.

[116]  G. Buckberg,et al.  The structure and function of the helical heart and its buttress wrapping. VI. Geometric concepts of heart failure and use for structural correction. , 2001, Seminars in thoracic and cardiovascular surgery.

[117]  B. Fagerberg,et al.  The Clinical Implications of Cognitive Impairment in Elderly Patients with Chronic Heart Failure , 2001, The Journal of cardiovascular nursing.

[118]  G. Buckberg,et al.  Surgical anterior ventricular endocardial restoration (SAVER) for dilated ischemic cardiomyopathy. , 2001, Seminars in thoracic and cardiovascular surgery.

[119]  G. Buckberg,et al.  Inferior wall restoration: anatomic and surgical considerations. , 2001, Seminars in thoracic and cardiovascular surgery.

[120]  G. Buckberg,et al.  Optimizing ventricular shape in anterior restoration. , 2001, Seminars in thoracic and cardiovascular surgery.

[121]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[122]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[123]  P. Poole‐Wilson,et al.  Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. , 2001, European heart journal.

[124]  K. Swedberg,et al.  Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.

[125]  M. Drazner,et al.  Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. , 2001, The New England journal of medicine.

[126]  S. Yusuf,et al.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.

[127]  W. Hermann,et al.  Results from post‐hoc analyses of the CIBIS II trial: effect of bisoprolol in high‐risk patient groups with chronic heart failure , 2001 .

[128]  M. Drazner,et al.  Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. , 2001, Journal of the American College of Cardiology.

[129]  U Ravens,et al.  Task Force on Sudden Cardiac Death of the European Society of Cardiology. , 2001, European heart journal.

[130]  J. Berlin,et al.  Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis. , 2001, American heart journal.

[131]  Eric J. Eichhorn.  Prognosis determination in heart failure. , 2001, The American journal of medicine.

[132]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[133]  D. Murdoch,et al.  ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects. , 2001, American heart journal.

[134]  J. Cleland,et al.  The heart failure epidemic: exactly how big is it? , 2001, European heart journal.

[135]  C. Schlensak,et al.  Left ventricular reduction for idiopathic dilated cardiomyopathy as alternative to transplant--truth or dare? , 2001, The Thoracic and cardiovascular surgeon.

[136]  G. Buckberg,et al.  Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. RESTORE group. Reconstructive Endoventricular Surgery, returning Torsion Original Radius Elliptical Shape to the LV. , 2001, Journal of the American College of Cardiology.

[137]  L. Wilhelmsen,et al.  Heart failure in the general population of men--morbidity, risk factors and prognosis. , 2001, Journal of internal medicine.

[138]  P. Ponikowski,et al.  Enhanced Ventilatory Response to Exercise in Patients With Chronic Heart Failure and Preserved Exercise Tolerance: Marker of Abnormal Cardiorespiratory Reflex Control and Predictor of Poor Prognosis , 2001, Circulation.

[139]  P. Dunselman.  Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators. , 2001, International journal of cardiology.

[140]  D. Kitzman,et al.  The pathogenesis of acute pulmonary edema associated with hypertension. , 2001, The New England journal of medicine.

[141]  D. Grobbee,et al.  [Drug-induced heart failure]. , 1999, Nederlands tijdschrift voor geneeskunde.

[142]  D. Khoury,et al.  Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. , 2001, Journal of the American College of Cardiology.

[143]  L. Tavazzi,et al.  Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. , 2001, Journal of the American College of Cardiology.

[144]  E. Philbin,et al.  Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. , 2000, The American journal of medicine.

[145]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[146]  J. Pell,et al.  Evidence of Improving Prognosis in Heart Failure: Trends in Case Fatality in 66 547 Patients Hospitalized Between 1986 and 1995 , 2000, Circulation.

[147]  Gabrielli,et al.  Determination of candidacy for mechanical circulatory support: importance of clinical indices , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[148]  P. Poole‐Wilson,et al.  Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. , 2000, Circulation.

[149]  H. Hense,et al.  Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population , 2000, Journal of hypertension.

[150]  J. McMurray,et al.  Do patients with suspected heart failure and preserved left ventricular systolic function suffer from “diastolic heart failure” or from misdiagnosis? A prospective descriptive study , 2000, BMJ : British Medical Journal.

[151]  S. Kaul,et al.  Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. , 2000, The American journal of cardiology.

[152]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[153]  Salim Yusuf,et al.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients , 2000, The Lancet.

[154]  Bertram Pitt,et al.  Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II , 2000, The Lancet.

[155]  S G Thompson,et al.  Survival of patients with a new diagnosis of heart failure: a population based study , 2000, Heart.

[156]  J. Spertus,et al.  Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. , 2000, Journal of the American College of Cardiology.

[157]  J. Cleland,et al.  Systematic review of the management of atrial fibrillation in patients with heart failure. , 2000, European heart journal.

[158]  H. Oswald,et al.  Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. , 2000, Circulation.

[159]  G. Bakris,et al.  Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? , 2000, Archives of internal medicine.

[160]  M. Domanski,et al.  The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. , 2000, Journal of the American College of Cardiology.

[161]  R. McKelvie,et al.  Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study. , 2000, Circulation.

[162]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[163]  B. Massie,et al.  Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. , 2000, Circulation.

[164]  J. Cleland,et al.  Is the prognosis of heart failure improving? , 1999, Journal of the American College of Cardiology.

[165]  E. Trulock,et al.  Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation. , 2000, Clinical transplants.

[166]  J S Child,et al.  Batista procedure: elliptical modeling against spherical distention. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[167]  N. Awan,et al.  A study of the efficacy and safety of irbesartan in combination with conventional therapy, including ACE inhibitors, in heart failure. Irbesartan Heart Failure Group. , 2000, International journal of clinical practice.

[168]  R A Nishimura,et al.  Assessment of right atrial pressure with 2-dimensional and Doppler echocardiography: a simultaneous catheterization and echocardiographic study. , 2000, Mayo Clinic proceedings.

[169]  D J Pennell,et al.  Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. , 2000, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[170]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[171]  P A Poole-Wilson,et al.  Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. , 1999, Circulation.

[172]  J. Bigger,et al.  Risk stratification for coronary bypass surgery in patients with left ventricular dysfunction: analysis of the coronary artery bypass grafting patch trial database. , 1999, Circulation.

[173]  H. S. Kim,et al.  Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation. , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[174]  Simon Stewart,et al.  Effects of a multidisciplinary, home-based intervention on planned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study , 1999, The Lancet.

[175]  A. Camm,et al.  Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. , 1999, The New England journal of medicine.

[176]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[177]  G. Alexopoulos,et al.  Respiratory muscles performance is related to oxygen kinetics during maximal exercise and early recovery in patients with congestive heart failure. , 1999, Circulation.

[178]  A. Pasquet,et al.  Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. , 1999, Circulation.

[179]  R. Novick,et al.  The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report--1999. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[180]  H. Abu‐Saad,et al.  Effects of education and support on self-care and resource utilization in patients with heart failure. , 1999, European heart journal.

[181]  I. Dimopoulou,et al.  Contribution of Lung Function to Exercise Capacity in Patients with Chronic Heart Failure , 1999, Respiration.

[182]  M. Domanski,et al.  Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction. , 1999, Journal of the American College of Cardiology.

[183]  A Hofman,et al.  Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. , 1999, European heart journal.

[184]  K. Bailey,et al.  Congestive heart failure in the community: trends in incidence and survival in a 10-year period. , 1999, Archives of internal medicine.

[185]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[186]  J. McMurray,et al.  Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992. , 1998, European heart journal.

[187]  M. Quiñones,et al.  Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue doppler imaging. , 1998, Circulation.

[188]  R. Prescott,et al.  Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). , 1998, Circulation.

[189]  S. Lévy,et al.  Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. , 1998, European heart journal.

[190]  B. Fagerberg,et al.  Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure. , 1998, European heart journal.

[191]  A. Toso,et al.  Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. , 1998, The Journal of thoracic and cardiovascular surgery.

[192]  L. Tavazzi,et al.  Reproducibility of the six-minute walking test in patients with chronic congestive heart failure: practical implications. , 1998, The American journal of cardiology.

[193]  F. Zannad,et al.  Clinical definition and epidemiology of advanced heart failure. , 1998, American heart journal.

[194]  S. Stewart,et al.  Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. , 1998, Archives of internal medicine.

[195]  M. Komajda,et al.  Risk stratification in chronic heart failure. , 1998, European heart journal.

[196]  L. Tavazzi,et al.  Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient. , 1998, Journal of the American College of Cardiology.

[197]  S. Bolling,et al.  Intermediate-term outcome of mitral reconstruction in cardiomyopathy. , 1998, The Journal of thoracic and cardiovascular surgery.

[198]  H. Tunstall-Pedoe,et al.  Biochemical detection of left-ventricular systolic dysfunction , 1998, The Lancet.

[199]  O. Faergeman,et al.  The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease. , 1997, Journal of cardiac failure.

[200]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[201]  P. Poole‐Wilson,et al.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care , 1997, The Lancet.

[202]  Hugh Tunstall-Pedoe,et al.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population , 1997, The Lancet.

[203]  J. Cohn,et al.  Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. , 1997, Circulation.

[204]  H. C. Kim,et al.  Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. , 1997, Journal of the American College of Cardiology.

[205]  P. Ponikowski,et al.  Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. , 1997, Circulation.

[206]  P. Ponikowski,et al.  Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1997, The American journal of cardiology.

[207]  C. Mulrow,et al.  Can the clinical examination diagnose left-sided heart failure in adults? , 1997, JAMA.

[208]  L. Pierard,et al.  Myocardial viability. Stress echocardiography vs nuclear medicine. , 1997, European heart journal.

[209]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[210]  S. Ogston,et al.  Cross sectional study of contribution of clinical assessment and simple cardiac investigations to diagnosis of left ventricular systolic dysfunction in patients admitted with acute dyspnoea , 1997, BMJ.

[211]  L. Tavazzi,et al.  Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. , 1997, Circulation.

[212]  G. Sinagra,et al.  Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. , 1997, Journal of the American College of Cardiology.

[213]  I. Holme,et al.  Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. , 1997, European heart journal.

[214]  A. Ciampi,et al.  Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators. , 1997, Journal of the American College of Cardiology.

[215]  G. Lamas,et al.  Ventricular dysfunction and the risk of stroke after myocardial infarction. , 1997, The New England journal of medicine.

[216]  J. Schwartz,et al.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1996, Circulation.

[217]  L. Erhardt,et al.  Simplified echocardiography in the diagnosis of heart failure. , 1997, Scandinavian cardiovascular journal : SCJ.

[218]  S. Jafri,et al.  Hypercoagulability in Heart Failure , 1997, Seminars in thrombosis and hemostasis.

[219]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[220]  S. Dubner,et al.  Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. , 1996, Circulation.

[221]  W. Stevenson,et al.  Improving survival for patients with atrial fibrillation and advanced heart failure. , 1996, Journal of the American College of Cardiology.

[222]  F Boomsma,et al.  Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group. , 1996, Journal of the American College of Cardiology.

[223]  A. Giordano,et al.  Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. , 1996, Journal of the American College of Cardiology.

[224]  L. Tavazzi,et al.  Concomitant factors of decompensation in chronic heart failure. , 1996, The American journal of cardiology.

[225]  F. Russel,et al.  Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. , 1996, Journal of the American College of Cardiology.

[226]  M. Weinberger,et al.  Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission. , 1996, The New England journal of medicine.

[227]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[228]  R. Falk,et al.  Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trials. , 1996, European heart journal.

[229]  T. Dormans,et al.  Chronic intermittent haemofiltration and haemodialysis in end stage chronic heart failure with oedema refractory to high dose frusemide. , 1996, Heart.

[230]  L. Sinoway,et al.  Hemodynamic effects of supplemental oxygen administration in congestive heart failure. , 1996, Journal of the American College of Cardiology.

[231]  P. Binkley,et al.  Role of spectral measures of heart rate variability as markers of disease progression in patients with chronic congestive heart failure not treated with angiotensin-converting enzyme inhibitors. , 1996, American heart journal.

[232]  J. Thomas,et al.  Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. , 1996, Journal of the American College of Cardiology.

[233]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[234]  J. Seward,et al.  New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy. , 1995, Journal of cardiology.

[235]  E. J. Benjamin,et al.  Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. , 1995, Journal of the American College of Cardiology.

[236]  U. Elkayam,et al.  Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. , 1995, Journal of the American College of Cardiology.

[237]  J. Thomas,et al.  Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. , 1995, Circulation.

[238]  P. Nihoyannopoulos,et al.  Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failure. , 1995, European heart journal.

[239]  C. Good,et al.  Diet and serum potassium in patients on ACE inhibitors. , 1995, JAMA.

[240]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[241]  D. Brater,et al.  Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure , 1995, Clinical pharmacology and therapeutics.

[242]  S. Bolling,et al.  Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. , 1995, The Journal of thoracic and cardiovascular surgery.

[243]  W. Stevenson,et al.  Risk of arterial embolization in 224 patients awaiting cardiac transplantation. , 1995, American heart journal.

[244]  B. Gersh,et al.  The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular function. , 1995, The American journal of cardiology.

[245]  A J Tajik,et al.  Two-Dimensional and Doppler Echocardiography Alone Can Adequately Define Preoperative Anatomy and Hemodynamic Status before Repair of Complete Atrioventricular Septal Defect in Infants <1 Year Old , 1994, Circulation.

[246]  D. Mann,et al.  Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. , 1994, Chest.

[247]  K. Channer,et al.  Combination diuretic treatment in severe heart failure: a randomised controlled trial. , 1994, British heart journal.

[248]  H. Ihlen,et al.  Intraventricular Early Diastolic Filling During Acute Myocardial Ischemia Assessment by Multigated Color M‐Mode Doppler Echocardiography , 1993, Circulation.

[249]  Bittner,et al.  Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. , 1993, JAMA.

[250]  William J. Rogers,et al.  Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction , 1993 .

[251]  G. Murray,et al.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .

[252]  P. Poole‐Wilson,et al.  Relation of pathophysiologic mechanisms to outcome in heart failure. , 1993, Journal of the American College of Cardiology.

[253]  G A Ewy,et al.  Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. , 1993, Journal of the American College of Cardiology.

[254]  J. McMurray,et al.  Trends in hospitalization for heart failure in Scotland 1980-1990. , 1993, European heart journal.

[255]  C Larizza,et al.  Predictors of prognosis in patients awaiting heart transplantation. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[256]  A J Camm,et al.  Heart rate variability: from facts to fancies. , 1993, Journal of the American College of Cardiology.

[257]  J. Cohn,et al.  Prognostic Significance of Serial Changes in Left Ventricular Ejection Fraction in Patients With Congestive Heart Failure , 1993, Circulation.

[258]  F. Tristani,et al.  Ejection Fraction, Peak Exercise Oxygen Consumption, Cardiothoracic Ratio, Ventricular Arrhythmias, and Plasma Norepinephrine as Determinants of Prognosis in Heart Failure , 1993, Circulation.

[259]  L. Hatle,et al.  Pulmonary venous flow velocities recorded by transthoracic Doppler ultrasound: relation to left ventricular diastolic pressures. , 1993, Journal of the American College of Cardiology.

[260]  K. Bailey,et al.  Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction , 1993, The Lancet.

[261]  M. Packer.  How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease. , 1993, The American journal of cardiology.

[262]  T. Rector,et al.  Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure. , 1993, Journal of the American College of Cardiology.

[263]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[264]  D. Mancini,et al.  Exertional Fatigue Due to Skeletal Muscle Dysfunction in Patients With Heart Failure , 1993, Circulation.

[265]  A. Donker,et al.  Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor. , 1993, The American journal of cardiology.

[266]  D. Cooper,et al.  Returning to work after heart transplantation. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[267]  H Just,et al.  Intraindividual Reproducibility of Heart Rate Variability , 1992, Pacing and clinical electrophysiology : PACE.

[268]  G. Steinbeck,et al.  A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. , 1992, The New England journal of medicine.

[269]  J. Cohn,et al.  Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. , 1992, American heart journal.

[270]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[271]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[272]  K. Swedberg,et al.  Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial). , 1992, The American journal of cardiology.

[273]  K. Hammermeister,et al.  Implications of third heart sounds in patients with valvular heart disease. The Veterans Affairs Cooperative Study on Valvular Heart Disease. , 1992, The New England journal of medicine.

[274]  G. Mancia,et al.  Reflex cardiovascular control in congestive heart failure. , 1992, The American journal of cardiology.

[275]  S Capewell,et al.  Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. , 1992, British heart journal.

[276]  Y. Hirota,et al.  Clinical significance of normal cardiac silhouette in dilated cardiomyopathy--evaluation based upon echocardiography and magnetic resonance imaging. , 1992, Japanese circulation journal.

[277]  A. Weyman,et al.  Calculation of atrioventricular compliance from the mitral flow profile: analytic and in vitro study. , 1992, Journal of the American College of Cardiology.

[278]  D. Cionni,et al.  Utility of the peak expiratory flow rate in the differentiation of acute dyspnea. Cardiac vs pulmonary origin. , 1992, Chest.

[279]  J. Cleland,et al.  Vascular tone in heart failure: the neuroendocrine-therapeutic interface. , 1991, British heart journal.

[280]  J. Dumesnil,et al.  Use of Valsalva maneuver to unmask left ventricular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension. , 1991, The American journal of cardiology.

[281]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[282]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[283]  M. Pfeffer,et al.  An overview of contemporary etiologies of congestive heart failure. , 1991, American heart journal.

[284]  J. Remes,et al.  Validity of clinical diagnosis of heart failure in primary health care. , 1991, European heart journal.

[285]  R. Bonow,et al.  Radionuclide angiographic evaluation of left ventricular diastolic function. , 1991, Circulation.

[286]  R. Myerburg,et al.  Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. , 1991, The American journal of medicine.

[287]  M. Luu,et al.  Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy , 1990 .

[288]  G. Sutton,et al.  Epidemiologic aspects of heart failure. , 1990, American heart journal.

[289]  S. Yusuf,et al.  Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). , 1990, Circulation.

[290]  K. Swedberg,et al.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.

[291]  H. Black,et al.  Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. , 1990, The American journal of cardiology.

[292]  A. Weyman,et al.  Analysis of the early transmitral Doppler velocity curve: effect of primary physiologic changes and compensatory preload adjustment. , 1990, Journal of the American College of Cardiology.

[293]  J. Berning,et al.  Early estimation of risk by echocardiographic determination of wall motion index in an unselected population with acute myocardial infarction. , 1990, The American journal of cardiology.

[294]  O. Smiseth,et al.  Left ventricular filling at elevated diastolic pressures: relationship between transmitral Doppler flow velocities and atrial contribution. , 1990, American heart journal.

[295]  M. Aoshima,et al.  [Problems in patients with use of a ventricular assist device]. , 1990, Journal of cardiology.

[296]  J. Marving,et al.  Symptoms and signs of heart failure in patients with myocardial infarction: reproducibility and relationship to chest X-ray, radionuclide ventriculography and right heart catheterization. , 1989, European heart journal.

[297]  M. Alam,et al.  Comparability of echocardiography and chest X‐ray following myocardial infarction , 1989, Journal of internal medicine.

[298]  F. Cecchi,et al.  Lack of correlation between intracavitary thrombosis detected by cross sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy. , 1989, British heart journal.

[299]  W. Rogers,et al.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.

[300]  M. Alam,et al.  Atrioventricular valve plane displacement in healthy persons. An echocardiographic study. , 2009, Acta medica Scandinavica.

[301]  D. Cook,et al.  Breathlessness, lung function and the risk of heart attack. , 1988, European heart journal.

[302]  A. Moss,et al.  Estimating left ventricular ejection fraction after myocardial infarction by various clinical parameters. , 1988, The American journal of cardiology.

[303]  R L Popp,et al.  Relation of Transmitral Flow Velocity Patterns to Left Ventricle Diastolic Function: New Insights From a Combined Hemodynamic and Doppler Echocardiographic Study , 1988, Journal of the American College of Cardiology.

[304]  M. Lebowitz,et al.  Objective radiographic criteria to differentiate cardiac, renal, and injury lung edema. , 1988, Investigative radiology.

[305]  M. A. Spiteri,et al.  RELIABILITY OF ELICITING PHYSICAL SIGNS IN EXAMINATION OF THE CHEST , 1988, The Lancet.

[306]  J P Wexler,et al.  The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. , 1988, Circulation.

[307]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[308]  S. Gottlieb,et al.  Prevention and reversal of nitrate tolerance in patients with congestive heart failure. , 1987, The New England journal of medicine.

[309]  C. Cipolla,et al.  Hemofiltration as short-term treatment for refractory congestive heart failure. , 1987, The American journal of medicine.

[310]  T. Hutchinson,et al.  Interobserver agreement by auscultation in the presence of a third heart sound in patients with congestive heart failure. , 1987, Chest.

[311]  P. Poole‐Wilson,et al.  Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. , 1987, British heart journal.

[312]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[313]  P. Poole‐Wilson,et al.  Factors determining symptoms in heart failure: comparison of fast and slow exercise tests. , 1986, British heart journal.

[314]  Michael V. Green,et al.  Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. , 1985, Circulation.

[315]  G. Guyatt,et al.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. , 1985, Canadian Medical Association journal.

[316]  A. Jatene.  Left ventricular aneurysmectomy. Resection or reconstruction. , 1985, The Journal of thoracic and cardiovascular surgery.

[317]  E. Gilpin,et al.  Usefulness of the chest x-ray for predicting abnormal left ventricular function after acute myocardial infarction. , 1984, American heart journal.

[318]  J. Polak,et al.  Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. , 1983, Journal of the American College of Cardiology.

[319]  H. Denolin,et al.  The defintion of heart failure , 1983 .

[320]  C. Higgins,et al.  Extravascular lung water in patients with congestive heart failure. Difference between patients with acute and chronic myocardial disease. , 1983, Radiology.

[321]  H. Kundel,et al.  Digital analysis of chest radiographs in pulmonary vascular congestion. , 1982, Radiology.

[322]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[323]  A. L. Simon,et al.  Correlations between the chest film and hemodynamics in acute myocardial infarction. , 1973, Circulation.

[324]  C. Edmonds,et al.  Total-body potassium in hypertension patients during prolonged diuretic therapy. , 1972, Lancet.

[325]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[326]  T. Petty,et al.  Long-term continuous oxygen therapy in chronic airway obstruction. Mortality in relationship to cor pulmonale, hypoxia, and hypercapnia. , 1970, Annals of internal medicine.

[327]  T. Killip,et al.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.

[328]  C. Friedberg.  DISEASES OF THE HEART , 1933, The Ulster Medical Journal.